Schedule of Convertible Subordinated Promissory Notes Issued to Pfizer Entities
Contract Categories:
Business Finance
›
Note Agreements
Summary
This document lists two convertible subordinated promissory notes issued by the company to Pfizer Ireland Pharmaceuticals and Pfizer Inc. The notes each have a principal amount of $10 million, with specified initial conversion prices and maturity dates. The agreement outlines the basic terms for these notes, including the parties involved, the amounts, and the dates when the notes mature. It serves as a record of these financial instruments and their key terms.
EX-4.4.2 2 a2182995zex-4_42.htm EXHIBIT 4.4.2
QuickLinks -- Click here to rapidly navigate through this document
QuickLinks -- Click here to rapidly navigate through this document
EXHIBIT 4.4.2
Schedule of Convertible Subordinated Promissory Notes Issued in the Form of Exhibit 4.4.1
| Date Issued | Name of Note Holder | Principal Amount | Initial Conversion Price | Maturity Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| February 3, 2006 | Pfizer Ireland Pharmaceuticals(1) | $ | 10,000,000 | $ | 6.8423 | February 3, 2013 | ||||
October 10, 2007 | Pfizer Inc. | $ | 10,000,000 | $ | 9.75 | October 10, 2014 | ||||
- (1)
- Formerly known as Pfizer Overseas Pharmaceuticals
QuickLinks
- EXHIBIT 4.4.2
